Inhibitory effects of phthalimide derivatives on the activity of the hepatic cytochrome P450 monooxygenases CYP2C9 and CYP2C19

By Kolukisaoglu Üner   Wendler Christian   Goerdes Dirk   Diener Annette   Thurow Kerstin  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 6, 2010-12 ,pp. : 876-886

Informa Healthcare

Access to resources Recommend Favorite

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid

By Melet A.   Assrir N.   Jean P.   Pilar Lopez-Garcia M.   Marques-Soares C.   Jaouen M.   Dansette P.M.   Sari M-A.   Mansuy D.  

Archives of Biochemistry and Biophysics, Vol. 409, Iss. 1, 2003-01 ,pp. : 80-91

Elsevier

Access to resources Recommend Favorite

Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1

By Kurata N.   Nishimura Y.   Iwase M.   Fischer N. E.   Tang B. K.   Inaba T.   Yasuhara H.  

Xenobiotica, Vol. 28, Iss. 11, 1998-11 ,pp. : 1041-1047

Informa Healthcare

Access to resources Recommend Favorite

CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification

By Hu Y.   Krausz K.   Gelboin H. V.   Kupfer D.  

Xenobiotica, Vol. 34, Iss. 2, 2004-02 ,pp. : 117-132

Informa Healthcare

Access to resources Recommend Favorite

Optimizing bacterial expression of catalytically active human cytochromes P450: comparison of CYP2C8 and CYP2C9

By Boye S. L.   Kerdpin O.   Elliot D. J.   Miners J. O.   Kelly L.   Mckinnon R. A.   Bhasker C. R.   Yoovathaworn K.   Birkett D. J.  

Xenobiotica, Vol. 34, Iss. 1, 2004-01 ,pp. : 49-60

Informa Healthcare

Access to resources Recommend Favorite